nach oben

Endocrine

Erschienen in:

14.12.2019 | Original Article

A 15 year institutional experience of well-differentiated follicular cell-derived thyroid carcinomas; impact of the new 2017 TNM and WHO Classifications of Tumors of Endocrine Organs on the epidemiological trends and pathological characteristics

verfasst von: Angela Borda, Ancuța-Elena Zahan, Doina Piciu, Elena Barbuș, Nicole Berger, Adela Nechifor-Boilă

Erschienen in: Endocrine | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Our study aimed to describe the evolution of the rate of pathological subtypes of well-differentiated follicular-cell derived thyroid carcinomas (DTCs) in the Department of Pathology, Emergency County Hospital Targu-Mures, Romania over a 15 year period and to assess the impact the new 2017 WHO and TNM classifications of thyroid tumors had on our cases.

Methods

The pathological data were retrieved from the original pathological reports. After applying the exclusion criteria the remaining cases were reviewed on a double-headed microscope and reclassified according to the 2017 WHO and TNM staging system. The follow-up data were collected from the Institute of Oncology Cluj-Napoca, Romania.

Results

Our study included 396 cases of DTCs (375 papillary, 11 follicular, and 10 Hürthle cell carcinomas). PTCs revealed a significant increasing trend over the study period, whereas follicular and Hurthle cell carcinomas remain rare; 125/131 of noninvasive encapsulated follicular variant PTC (EFVPTC) were reclassified as noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTPs), resulting in a 33.3% reduction in the number of PTCs. According to 2017 TNM stage-grouping 31% of 271 patients with DTC were downstaged. Follow-up data were available for most of the patients (65.7%, mean period 58.1 months). All patients with noninvasive EFVPTC were disease free at the last clinical assessment.

Conclusions

The increasing rate of PTC was maintained even after exclusion of NIFTP. By applying 2017 TNM criteria, a significant number of DTC cases were downstaged into a more favorable group. Follow-up data highlight the indolent behavior of noninvasive EFVPTCs reclassified as NIFTPs.

B.W. Stewart, C. Wild, World Cancer Report, 3rd edn. (International Agency for Research on Cancer (IARC), Lyon, 2014)

J. Ferlay, M. Colombet, I. Soerjomataram, T. Dyba et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur. J. Cancer 103, 356–387 (2018)CrossRefPubMed

Y.E. Nikiforov, P.W. Biddinger, L.D.R. Thompson, Diagnostic Pathology and Molecular Genetics of the Thyroid (Lippincott, Williams and Wilkins, Philadelphia, USA, 2012)

N. Berger, A. Borda, Pathologie thyroidienne, parathyroidienne et surrenalienne (Sauramps Medical, Montpellier, France, 2010)

R.V. Lloyd, R.Y. Osamura, G. Kloppel, J. Rosai, WHO Classification of Tumours of Endocrine Organs (International Agency for Research on Cancer (IARC), Lyon, 2017)

L. Davies, H.G. Welch, Current thyroid cancer trends in the United States. JAMA. Otolaryngol. Head. Neck Surg. 140(4), 317–322 (2014)

L. Davies, How understanding thyroid cancer in Belgium can help us mitigate the problem of increasing incidence. J. Clin. Endocrinol. Metab. 98(10), 3977–3979 (2013)CrossRefPubMed

Y. Ito, Y.E. Nikiforov, M. Schlumberger, R. Vigneri, Increasing incidence of thyroid cancer: controversies explored. Nat. Rev. Endocrinol. 9(3), 178–184 (2013)CrossRefPubMed

J. Albores-Saavedra, D.E. Henson, E. Glazer, A.M. Schwartz, Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype–papillary, follicular, and anaplastic: a morphological and epidemiological study. Endocr. Pathol. 18(1), 1–7 (2007)CrossRefPubMed

10.

C.K. Jung, M.P. Little, J.H. Lubin, A.V. Brenner et al. The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. J. Clin. Endocrinol. Metab. 99(2), E276–E285 (2014)CrossRefPubMed

11.

B. Amphlett, Z. Lawson, G.O. Abdulrahman Jr., C. White et al. Recent trends in the incidence, geographical distribution, and survival from thyroid cancer in Wales, 1985–2010. Thyroid 23(11), 1470–1478 (2013)CrossRefPubMed

12.

Y. Mao, M. Xing, Recent incidences and differential trends of thyroid cancer in the USA. Endocr. Relat. Cancer 23(4), 313–322 (2016)CrossRefPubMedPubMedCentral

13.

C. Lupi, R. Giannini, C. Ugolini, A. Proietti et al. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 92(11), 4085–4090 (2007)CrossRefPubMed

14.

L. Davies, H.G. Welch, Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295, 2164–2167 (2006)CrossRefPubMed

15.

D. Piciu, A. Irimie, A. Piciu, Investigation of thyroid carcinoma over 40 years, using the database of the Ion Chiricuta Institute of Oncology Cluj-Napoca. J. BUON 19, 524–529 (2014)PubMed

16.

J.P. Brito, N.A. Al, V.M. Montori, I.D. Hay et al. The impact of subclinical disease and mechanism of detection on the rise in thyroid cancer incidence: a population-based study in Olmsted County, Minnesota during 1935 through 2012. Thyroid 25(9), 999–1007 (2015)CrossRefPubMedPubMedCentral

17.

D. Piciu, Thyroid cancer incidence 25 years after Chernobyl, in a Romanian cancer center: is it a public health problem? Curr. Radiopharm. 6, 249–252 (2013)CrossRefPubMed

18.

L.G. Morris, A.G. Sikora, T.D. Tosteson, L. Davies, The increasing incidence of thyroid cancer: the influence of access to care. Thyroid 23(7), 885–891 (2013)CrossRefPubMedPubMedCentral

19.

H.S. Ahn, H.J. Kim, H.G. Welch, Korea's thyroid-cancer “epidemic”–screening and overdiagnosis. N. Engl. J. Med. 371(19), 1765–1767 (2014)CrossRefPubMed

20.

H.G. Welch, W.C. Black, Overdiagnosis in cancer. J. Natl Cancer Inst. 102(9), 605–613 (2010)CrossRefPubMed

21.

S. Lindsay. Carcinoma of the Thyroid Gland: a Clinical and Pathological Study of 293 Patients at the University of California Hospital (Charles C Thomas, Springfield, USA, 1960)

22.

K.T. Chem, J. Rosai, Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases. Am. J. Surg. Pathol. 1, 123–130 (1977)CrossRefPubMed

23.

V.A. LiVolsi, S.L. Asa, The demise of follicular carcinoma of the thyroid gland. Thyroid 4, 233–236 (1994)CrossRefPubMed

24.

J. Zidan, D. Karen, M. Stein, E. Rosenblatt et al. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer 97(5), 1181–1185 (2003)CrossRefPubMed

25.

S. Ertek, N.C. Yilmaz, A.F. Cicero, O. Vurupalmaz et al. Increasing diagnosis of thyroid papillary carcinoma follicular variant in south-east Anatolian region: comparison of characteristics of classical papillary and follicular variant thyroid cancers. Endocr. Pathol. 23(3), 157–160 (2012)CrossRefPubMed

26.

J. Liu, B. Singh, G. Tallini, D.L. Carlson et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 107, 1255–1264 (2006)CrossRefPubMed

27.

M. Rivera, J. Ricarte-Filho, J. Knauf, A. Shaha et al. Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod. Pathol. 23(9), 1191–1200 (2010)CrossRefPubMedPubMedCentral

28.

M. Vivero, S. Kraft, J.A. Barletta, Risk stratification of follicular variant of papillary thyroid carcinoma. Thyroid 23(3), 273–279 (2013)CrossRefPubMed

29.

B.E. Howitt, Y. Jia, L.M. Sholl, J.A. Barletta, Molecular alterations in partially-encapsulated or well-circumscribed follicular variant of papillary thyroid carcinoma. Thyroid 23(10), 1256–1262 (2013)CrossRefPubMed

30.

M. Rivera, R.M. Tuttle, S. Patel, A. Shaha et al. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid 19(2), 119–127 (2009)CrossRefPubMed

31.

I. Ganly, L. Wang, R.M. Tuttle, N. Katabi et al. Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant. Hum. Pathol. 46(5), 657–664 (2015)CrossRefPubMedPubMedCentral

32.

B.E. Howitt, V.A. Paulson, J.A. Barletta, Absence of BRAF V600E in non-infiltrative, non-invasive follicular variant of papillary thyroid carcinoma. Histopathology 67(4), 579–582 (2015)CrossRefPubMed

33.

Y.E. Nikiforov, R.R. Seethala, G. Tallini, Z.W. Baloch et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2, 1023–1029 (2016)CrossRefPubMedPubMedCentral

34.

P.W. Rosario, G.C. Penna, M.R. Calsolari, Noninvasive encapsulated follicular variant of papillary thyroid carcinoma: is lobectomy sufficient for tumours ≥1 cm? Clin. Endocrinol. 81(4), 630–632 (2014)CrossRef

35.

L.D. Thompson, Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: a name change to noninvasive follicular thyroid neoplasm with papillary-like nuclear features would help prevent overtreatment. Mod. Pathol. 29(7), 698–707 (2016)CrossRefPubMed

36.

A.R. Burningham, J. Krishnan, B.J. Davidson, M.D. Ringel et al. Papillary and follicular variant of papillary carcinoma of the thyroid: initial presentation and response to therapy. Otolaryngol. Head Neck Surg. 132(6), 840–844 (2005)CrossRefPubMed

37.

Y. Nikiforov, G. Randolph, R. Ghossein, et al. Non-invasive follicular thyroid neoplasm with papillary-like nuclear features, in R.V. Lloyd, R.Y. Osamura, J.P. Klopper, J. Rosai (eds.) WHO Classification of Tumors of Endocrine Organs (International Agency for Research on Cancer (IARC), Lyon, 2017), pp. 78–80

38.

J.D. Brierley, M. Gospodarowicz, C. Wittekind, UICC/TNMClassification of Malignant Tumors, 8th edn. (John Wiley & Sons, Oxford, UK, 2017)

39.

R.A. DeLellis, E.D. Williams, Pathology of the thyroid and parathyroid. in R.A. DeLellis, R.V. Lloyd, P.U. Heitz (eds.) Pathology and Genetics of Tumors of Endocrine Organs, (International Agency for Research on Cancer (IARC Press), Lyon, 2004), p. 57–66

40.

L.H. Sobin, M. Gospodarowicz, C. Wittekind, UICC/TNM Classification of Malignant Tumors, 7th edn. (John Wiley & Sons, Oxford, UK, 2009)

41.

B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1), 1–133 (2016)CrossRefPubMedPubMedCentral

42.

B.R. Haugen, A.M. Sawka, E.K. Alexander, K.C. Bible et al. American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Thyroid 27, 481–483 (2017)CrossRefPubMed

43.

C.M. Kiernan, V.L. Weiss, M. Mehrad, K. Ely et al. New terminology-noninvasive follicular neoplasm with papillary-like nuclear features (NIFTP) and its effect on the rate of malignancy at a single institution. Surgery 163, 55–59 (2018)CrossRefPubMed

44.

K. O'Hare, E. O'Regan, A. Khattak, M.L. Healy et al. Reclassification as NIFTP: a retrospective review in a single institution with an emphasis on workload. Endocr. Pathol. 29, 231–235 (2018)CrossRefPubMed

45.

M.L. Mao, T. Joyal, O. Picado, D. Kerr et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features reclassification and its impact on thyroid malignancy rate and treatment. J. Surg. Res. 230, 47–52 (2018)CrossRefPubMed

46.

K.S. Wong, K.C. Strickland, T.E. Angell, M.A. Nehs et al. The flip side of NIFTP: an increase in rates of unfavorable histologic parameters in the remainder of papillary thyroid carcinomas. Endocr. Pathol. 28, 171–176 (2017)CrossRefPubMed

47.

A. Bychkov, C.K. Jung, Z. Liu, K. Kakudo, Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in asian practice: perspectives for surgical pathology and cytopathology. Endocr. Pathol. 29, 276–288 (2018)CrossRefPubMedPubMedCentral

48.

G. Grani, L. Lamartina, C. Durante, S. Filetti et al. Follicular thyroid cancer and Hurthle cell carcinoma: challenges in diagnosis, treatment, and clinical management. Lancet Diabetes Endocrinol. 6, 500–514 (2018)CrossRefPubMed

49.

G. Tallini, R.M. Tuttle, R.A. Ghossein, The history of the follicular variant of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 102, 15–22 (2017)PubMed

50.

R.V. Lloyd, L.A. Erickson, M.B. Casey, K.Y. Lam et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am. J. Surg. Pathol. 28, 1336–1340 (2004)CrossRefPubMed

51.

L. Lamartina, G. Grani, E. Arvat, A. Nervo et al. 8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2). Endocr. Relat. Cancer 25, L7–L11 (2018)CrossRefPubMed

52.

M. Kim, W.G. Kim, H.S. Oh, S. Park et al. Comparison of the seventh and eighth editions of the American Joint Committee on Cancer/Union for International Cancer Control Tumor-Node-Metastasis Staging System for Differentiated Thyroid Cancer. Thyroid 27, 1149–1155 (2017)CrossRefPubMed

53.

Z.W. Baloch, K. Shafique, M. Flannagan, V.A. LiVolsi, Encapsulated classic and follicular variants of papillary thyroid carcinoma: comparative clinicopathologic study. Endocr. Pract. 16(6), 952–959 (2010)CrossRefPubMed

54.

Z.W. Baloch, V.A. LiVolsi, Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod. Pathol. 13(8), 861–865 (2000)CrossRefPubMed

Titel: A 15 year institutional experience of well-differentiated follicular cell-derived thyroid carcinomas; impact of the new 2017 TNM and WHO Classifications of Tumors of Endocrine Organs on the epidemiological trends and pathological characteristics
verfasst von: Angela Borda
Ancuța-Elena Zahan
Doina Piciu
Elena Barbuș
Nicole Berger
Adela Nechifor-Boilă
Publikationsdatum: 14.12.2019
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 3/2020
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-019-02158-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours

Acute glycemic variability on admission predicts the prognosis in hospitalized patients with coronary artery disease: a meta-analysis

Thyroid profile during the alternative Sunitinib dosing 2/1 schedule in metastatic renal cell carcinoma

Stumbling broke the spleen and unveiled pheochromocytoma, which in turn broke the heart

Correction to: Association of the genetic variants of insulin receptor substrate 1 (IRS-1) with type 2 diabetes mellitus in a Saudi population